{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T23:06:38Z","timestamp":1780441598738,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["17K11223"],"award-info":[{"award-number":["17K11223"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>We previously reported that tamoxifen (TAM)-induced ovarian hyperstimulation (OHS) is associated with high serum concentrations of estradiol in premenopausal women with breast cancer. To investigate risk factors for TAM-induced OHS, we performed a retrospective multicenter study.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Premenopausal patients who received surgical therapy for endocrine-dependent breast cancer (<jats:italic>n<\/jats:italic>\u2009=\u2009235) were recruited in this study and classified into 4 groups: group A, treated with TAM alone; group B, TAM treatment after 2-year-combined therapy with a gonadotropin-releasing hormone (Gn-RH) agonist; group C, TAM treatment after chemotherapy; group D, 5-year-combined therapy with TAM and a Gn-RH agonist. A serum estradiol value of more than 300\u2009pg\/mL or mean follicular diameter of more than 30\u2009mm was defined as OHS.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The incidence of OHS in group A (<jats:italic>n<\/jats:italic>\u2009=\u200913\/26, 50.0%) was significantly higher than those in group B (<jats:italic>n<\/jats:italic>\u2009=\u200917\/63, 27.0%), group C (<jats:italic>n<\/jats:italic>\u2009=\u200920\/110, 18.2%), and group D (<jats:italic>n<\/jats:italic>\u2009=\u20090\/36, 0%). The incidence of OHS was significantly correlated with aging, and the median serum concentration of estradiol in the presence of OHS was 823.0\u2009pg\/mL. The incidence of OHS (less than 47\u2009years old) was 62.5% in group A, 48.6% in group B, and 28.2% in group C, respectively. Notably, the incidence rate of OHS following amenorrhea in group C (<jats:italic>n<\/jats:italic>\u2009=\u200913\/20, 65.0%) was significantly higher than that in group B (<jats:italic>n<\/jats:italic>\u2009=\u20091\/17, 5.9%).<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>These findings indicate that the onset of OHS following amenorrhea was common in the post-chemotherapeutic group, while its ratio was low in the group after Gn-RH analog treatment, suggesting that combined treatment-based management involving TAM therapy is necessary for premenopausal patients with breast cancer.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12885-020-6549-5","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T10:03:06Z","timestamp":1580292186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ovarian hyperstimulation closely associated with resumption of follicular growth after chemotherapy during tamoxifen treatment in premenopausal women with breast cancer: a multicenter retrospective cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Rena","family":"Yamazaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoko","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Ayabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Jinno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subaru","family":"Myojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Tangoku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Kita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoharu","family":"Sugie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3098-9406","authenticated-orcid":false,"given":"Hiroshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"key":"6549_CR1","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/jjco\/hyv002","volume":"45","author":"K Katanoda","year":"2015","unstructured":"Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, Soda M, Ioka A, Sobue T, Nishimoto H. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol. 2015;45:390\u2013401. https:\/\/doi.org\/10.1093\/jjco\/hyv002.","journal-title":"Jpn J Clin Oncol"},{"key":"6549_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12282-013-0470-6","volume":"22","author":"K Uchida","year":"2015","unstructured":"Uchida K, Ohashi H, Kinoshita S, Nogi H, Kato K, Toriumi Y, Yamashita A, Kamio M, Mimoto R, Takeyama H. Breast cancer screening and the changing population pyramid of Japan. Breast Cancer. 2015;22:172\u20136. https:\/\/doi.org\/10.1007\/s12282-013-0470-6.","journal-title":"Breast Cancer"},{"issue":"Pt 3","key":"6549_CR3","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.mce.2014.11.015","volume":"418","author":"B Huang","year":"2015","unstructured":"Huang B, Warner M, Gustafsson J\u00c5. Estrogen receptors in breast carcinogenesis and endocrine therapy. Mol Cell Endocrinol. 2015;418(Pt 3):240\u20134. https:\/\/doi.org\/10.1016\/j.mce.2014.11.015.","journal-title":"Mol Cell Endocrinol"},{"key":"6549_CR4","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1200\/JCO.2015.65.9573","volume":"34","author":"HJ Burstein","year":"2016","unstructured":"Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KE, Giordano SH, Hudis CA, Solky AJ, Stearns V, Winer EP, Griggs JJ. Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline update on ovarian suppression. J Clin Oncol. 2016;34:1689\u2013701. https:\/\/doi.org\/10.1200\/JCO.2015.65.9573.","journal-title":"J Clin Oncol"},{"key":"6549_CR5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s12282-016-0670-y","volume":"23","author":"T Aihara","year":"2016","unstructured":"Aihara T, Toyama T, Takahashi M, Yamamoto Y, Hara F, Akabane H, Fujisawa T, Ishikawa T, Nagai S, Nakamura R, Tsurutani J, Ito Y, Mukai H. The Japanese breast cancer society clinical practice guideline for systemic treatment of breast cancer, 2015 edition. Breast Cancer. 2016;23:329\u201342. https:\/\/doi.org\/10.1007\/s12282-016-0670-y.","journal-title":"Breast Cancer"},{"key":"6549_CR6","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1677\/joe.0.0700421","volume":"70","author":"GV Groom","year":"1976","unstructured":"Groom GV, Griffiths K. Effect of the anti-oestrogen tamoxifen on plasma levels of luteinizing hormone, follicle-stimulating hormone, prolactin, oestradiol and progesterone in normal pre-menopausal women. J Endocrinol. 1976;70:421\u20138.","journal-title":"J Endocrinol"},{"key":"6549_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejogrb.2018.06.022","volume":"228","author":"L Jie","year":"2018","unstructured":"Jie L, Li D, Yang C, Haiying Z. Tamoxifen versus clomiphene citrate for ovulation induction in infertile women. Eur J Obstet Gynecol Reprod Biol. 2018;228:57\u201364.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"6549_CR8","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1093\/jnci\/83.20.1488","volume":"83","author":"VC Jordan","year":"1994","unstructured":"Jordan VC, Fritz NF, Langan-Fahey S, Thompson M, Tormey DC. Alteration of endocrine parameters in premenopausal women with breast cancer during long-term adjuvant therapy with tamoxifen as the single agent. J Natl Cancer Inst. 1994;83:1488\u201391.","journal-title":"J Natl Cancer Inst"},{"key":"6549_CR9","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/oxfordjournals.humrep.a138723","volume":"9","author":"A Shulman","year":"1994","unstructured":"Shulman A, Cohen I, Altaras MM, Maymon R, Ben-Nun I, Tepper R, Beyth Y. Ovarian cyst formation in two pre-menopausal patients treated with tamoxifen for breast cancer. Hum Reprod. 1994;9:1427\u20139.","journal-title":"Hum Reprod"},{"key":"6549_CR10","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S0002-9378(96)70386-1","volume":"174","author":"A Shushan","year":"1996","unstructured":"Shushan A, Peretz T, Uziely B, Lewin A, Mor-Yosef S. Ovarian cysts in premenopausal and postmenopausal tamoxifen-treated women with breast cancer. Am J Obstet Gynecol. 1996;174:141\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"6549_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1038\/sj.bjc.6690280","volume":"79","author":"MJ Mourits","year":"1999","unstructured":"Mourits MJ, de Vries EG, Willemse PH, ten Hoor KA, Hollema H, Sluiter WJ, de Bruijn HW, van der Zee AG. Ovarian cysts in women receiving tamoxifen for breast cancer. Br J Cancer. 1999;79:1761\u20134.","journal-title":"Br J Cancer"},{"key":"6549_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1006\/gyno.1998.5201","volume":"72","author":"I Cohen","year":"1999","unstructured":"Cohen I, Figer A, Tepper R, Shapira J, Altaras MM, Yiagel D, Beyth Y. Ovarian overstimulation and cystic formation in premenopausal tamoxifen exposure: comparison between tamoxifen-treated and nontreated breast cancer patients. Gynecol Oncol. 1999;72:202\u20137.","journal-title":"Gynecol Oncol"},{"key":"6549_CR13","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3892\/ol.2014.2319","volume":"8","author":"C Madeddu","year":"2014","unstructured":"Madeddu C, Gramignano G, Kotsonis P, Paribello F, Macci\u00f2 A. Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine-dependent breast cancer: a report of two cases. Oncol Lett. 2014;8:1279\u201382.","journal-title":"Oncol Lett"},{"key":"6549_CR14","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s40064-015-1223-0","volume":"4","author":"R Yamazaki","year":"2015","unstructured":"Yamazaki R, Inokuchi M, Ishikawa S, Myojo S, Iwadare J, Bono Y, Mizumoto Y, Nakamura M, Takakura M, Iizuka T, Ohta T, Fujiwara H. Tamoxifen-induced ovarian hyperstimulation during premenopausal hormonal therapy for breast cancer in Japanese women. Springerplus. 2015;4:425. https:\/\/doi.org\/10.1186\/s40064-015-1223-0 eCollection 2015.","journal-title":"Springerplus"},{"key":"6549_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1037\/h0044320","volume":"57","author":"TH Ryan","year":"1960","unstructured":"Ryan TH. Significance tests for multiple comparison of proportions, variances, and other statistics. Psychol Bull. 1960;57:318.","journal-title":"Psychol Bull"},{"key":"6549_CR16","doi-asserted-by":"publisher","first-page":"615","DOI":"10.5468\/ogs.2018.61.5.615","volume":"61","author":"S Lee","year":"2018","unstructured":"Lee S, Kim YH, Kim SC, Joo JK, Seo DS, Kim KH, Lee KS. The effect of tamoxifen therapy on the endometrium and ovarian cyst formation in patients with breast cancer. Obstet Gynecol Sci. 2018;61:615\u201320. https:\/\/doi.org\/10.5468\/ogs.2018.61.5.615.","journal-title":"Obstet Gynecol Sci"},{"key":"6549_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/4931852","volume":"2018","author":"Nobue Kojima","year":"2018","unstructured":"Kojima N, Yamasaki Y, Koh H, Miyashita M, Morita H. Long-acting luteinizing hormone-releasing hormone agonist for ovarian hyperstimulation induced by tamoxifen for breast cancer. Case Rep Obstet Gynecol. 2018;4931852. https:\/\/doi.org\/10.1155\/2018\/4931852.","journal-title":"Case Reports in Obstetrics and Gynecology"},{"key":"6549_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.critrevonc.2017.03.009","volume":"113","author":"G Codacci-Pisanelli","year":"2017","unstructured":"Codacci-Pisanelli G, Del Pup L, Del Grande M, Peccatori FA. Mechanisms of chemotherapy-induced ovarian damage in breast cancer patients. Crit Rev Oncol Hematol. 2017;113:90\u20136. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.03.009.","journal-title":"Crit Rev Oncol Hematol"},{"key":"6549_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/molehr\/gaw070","volume":"23","author":"AC Yding","year":"2017","unstructured":"Yding AC. Inhibin-B secretion and FSH isoform distribution may play an integral part of follicular selection in the natural menstrual cycle. Mol Hum Reprod. 2017;23:16\u201324. https:\/\/doi.org\/10.1093\/molehr\/gaw070.","journal-title":"Mol Hum Reprod"},{"key":"6549_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jsbmb.2013.08.015","volume":"142","author":"GE Hale","year":"2014","unstructured":"Hale GE, Robertson DM, Burger HG. The perimenopausal woman: endocrinology and management. J Steroid Biochem Mol Biol. 2014;142:121\u201331. https:\/\/doi.org\/10.1016\/j.jsbmb.2013.08.015.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"6549_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006254-198701000-00001","volume":"42","author":"JL Andreyko","year":"1987","unstructured":"Andreyko JL, Marshall LA, Dumesic DA, Jaffe RB. Therapeutic uses of gonadotropin-releasing hormone analogs. Obstet Gynecol Surv. 1987;42:1\u201321.","journal-title":"Obstet Gynecol Surv"},{"key":"6549_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.fertnstert.2016.10.020","volume":"107","author":"LM Shandley","year":"2017","unstructured":"Shandley LM, Spencer JB, Fothergill A, Mertens AC, Manatunga A, Paplomata E, Howards PP. Impact of tamoxifen therapy on fertility in breast cancer survivors. Fertil Steril. 2017;107:243\u201352.","journal-title":"Fertil Steril"},{"key":"6549_CR23","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/bjs.10899","volume":"105","author":"CA Fleming","year":"2018","unstructured":"Fleming CA, Heneghan HM, O'Brien D, McCartan DP, McDermott EW, Prichard RS. Meta-analysis of the cumulative risk of endometrial malignancy and systematic review of endometrial surveillance in extended tamoxifen therapy. Br J Surg. 2018;105:1098\u2013106.","journal-title":"Br J Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-020-6549-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-020-6549-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,28]],"date-time":"2021-01-28T00:12:57Z","timestamp":1611792777000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-020-6549-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["6549"],"URL":"https:\/\/doi.org\/10.1186\/s12885-020-6549-5","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,29]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This retrospective study was approved by the Medical Ethics Committee of Kanazawa University (no. 2197\u20131), Tokushima University Graduate School (no. 2958\u20131), Teikyo University School of Medicine (no. 15\u2013189), and Kansai Medical University (no. 2017003). Permission of use of clinical data was obtained from each patient before operation. Informed consent of using these clinical data for this study was additionally obtained by the method of opt-out on the website from the patients according to instruction by ethical committees.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}